WE ARE WAKAMONO
The current COVID-19 pandemic caused by the SARS-CoV-2 virus is tearing global health systems apart. COVID-19 is not only a critical threat for the population with risk factors, but also generates a dramatic economic impact in terms of morbidity and the overall interruption of economic activities.
Wakamono was established more than 10 years since 2010. We are a global leader in the field of Nanobiotech research and create innovative solutions globally based on our core values of Sustainability, Health, and Comfort, striving for the well-being of people, society and our planet Earth through our widely innovative product.